Call +1 501-258-5185
Call +1 501-258-5185

Dr. Stanley Lau​

Fellow Of the american college of cardiology
Board Certified Interventional Cardiologist trained at the University of Southern California and specialized in diagnostic cardiac catheterization, coronary angioplasty, Atherectomy, coronary artery stenting, intravascular ultrasound, renal and peripheral diagnostic angiograms, and pacemaker implantation.
Summary of qualifications
  • Board certified in lnterventional Cardiology (2018)
  • Board-certified in Cardiovascular Disease (1996, recertified in 2005 and 2015)
  • Board-certified in Internal Medicine (1991, recertified in 2002 and 2012)
  • Board certified in Certification Board of Cardiovascular Computed Tomography, CBCCT (2008)
  • Board-certified in Echocardiography subspecialty (1999)
  • Board-certified in Acute Critical Care Echocardiography subspecialty (2022)
  • Board-certified in Nuclear Cardiology subspecialty (1996)
  • Board-certified as Hypertension Specialist (2003)
  • Level Ill Certification (Director Level, highest level of expertise) in CCTA by the Society of Cardiovascular Computed Tomography (SCCT)
  • Level II Certification in Cardiac MR by the Society of Cardiovascular Magnetic Resonance (SCMR)
Medical License
  • State of California, USA- A46648 since 1989
  • Licensed in Hong Kong since 1985, then registered as a cardiology specialist
Work Experience

March 2023 to Current Medical Director MDVISIT CLINIC California, USA Providing

  • September 2006 to 2-23
    • Founder, MedicalDirector Synergy Imaging Center.Synergy Imaging Center is a state-of-the-art multi-modality facility providing the most advanced imaging throughout the entire San Gabriel Valley. Synergy is also home to the most advanced cardiac imaging technology, namely
Coronary CT and Angiogram and Cardiac MRI
  • November 1997 to 2023 Founder
    • Southern California Heart Centers, San Gabriel, California, USA, provides cardiovascular services in the Greater Los Angeles Area and conducts cardiovascular research.
  • November 1996 to November 1997
    • Assistant Professor in Cardiology, Texas Tech University, Lubbock, Texas, USA Training cardiology fellows in an accredited cardiology training program
  • August 1995 to November 1996
    • Cardiovascular Consultant at Chandra Cardiovascular Consultant, PC Sioux City, Iowa, USA
    • Providing clinical service in rural area serving the locals and American Indians.
    • Started one of the earliest primary angioplasty programs with no surgical backup.
Post-graduate Training
  • April 2006
    • Cardiac CT Fellowship Program, The Heart Center of Alabama, Huntsville, Alabama, USA
  • July 1994 to June 1995
    • lnterventional Cardiology Fellowship, University of Southern California, Los Angeles, California, USA
  • July 1991to June 1994
    • Cardiology Fellowship, University of Southern California, Los Angeles, California, USA
  • July 1989 to June 1991
    • Residency in Internal Medicine, University of Southern California, Los Angeles, California, USA
  • July 1988 to June 1989
    • Internship in Internal Medicine, University of Southern California, Los Angeles, California, USA
Education
  • 1978 to 1984
    • M.B.B.S. (Bachelor of Medicine & Bachelor of Surgery) School of Medicine University of New South Wales, Sydney, Australia
Clinical Appointments
  • 2018 to present
    • Director, Cardiac Structural Heart Program, Garfield Medical Center
      525 N Garfield Ave, Monterey Park, CA 91754
  • 2017 to present
    • Chairman, Cardiovascular Committee, Garfield Medical Center
      525 N Garfield Ave, Monterey Park, CA. 91754
  • 2016 to present
    • Board of Directors, The Governing Board, Garfield Medical Center
      525 N Garfield Ave, Monterey Park, CA. 91754
  • 2015
    • Chief of Staff, Garfield Medical Center
      525 N Garfield Ave, Monterey Park, CA. 91754
  • 2013 to present
    • Los Angeles County certified ST-Elevation Myocardial Infarction (STEMI) Program Director, Garfield Medical Center,
      525 N Garfield Ave, Monterey Park, CA. 91754
  • 2013 to present
    • Director, Cardiac Catheterization Lab, Garfield Medical Center
      525 N Garfield Ave, Monterey Park, CA. 91754
  • 2013,2010,2005,2004,2002
    • Chairman, Critical Care Committee, Garfield Medical Center
      525 N Garfield Ave, Monterey Park, CA. 91754
Professional Titles
FACC Fellow, American College of Cardiology
FACA Fellow, American College of Angiology
Professional Memberships
Member American College of Cardiology (ACC)
Member American College of Nuclear Cardiology
(ACNC) Member American Society of Echocardiography (ASE)
Member American Society of Hypertension (ASH)
Member Society of Cardiovascular Magnetic Resonance Imaging (SCMR)
Founding Member (SCCT) Society of Cardiovascular Computed Tomography
Research Activities
Principal Investigator, “Evaluation of the Safety and Efficacy of the OPTIMIZER II System with Active Fixation Leads in Subjects with Heart Failure Resulting from Systolic Dysfunction: FIX-HF-4/FIX-HF-5 Studies”
2004 FDA Phase I completed
2005 FDA Phase 11
2009 Completion
A multi-center clinical trial investigating the use of Cardiac Contractility Modulation (CCM) therapy to improve outcomes for NYHA Class Ill and IV heart failure patients
Publications
  • Davis A, Chiu J, Lau SK, Kok YJ, Wu JYH. Efficacy of Implementation of a Chest Pain Center at at Community Hospital. Grit Pathw Cardio. 2017 Dec:16(4): 135- 141
  • Saint-Martin, P, Rogers, C, Carpenter, E, Fishbein MC, Lau, S, Sathyavagiswaran, L: Subaortic Pseudo-Aneurysm of the Left Ventricle Complicating Staphyloccal Endocartidis. Journal of Forensic Sciences. 2009, 08:247.
  • Abraham, William T MD, Burkhoff, Daniel MD, PhD, Nademanee, Koonlawee, MD, Carson, Peter MD, Bourge, Robert MD, Ellenbogen, Kenneth MD, Parides, Michael PhD, Kadish, Alan MD, on behalf of the FIX-HF-5 Investigators and Coordinators: A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: Rationale. design. and baseline patient characteristics. American Heart Journal. 156(4):641- 648e1, October 2008.
  • Jenkins LA, Lau SK, Crawford M and Keung YK: Delayed Profound Thrombocytopenia After c7E3 Fab (Abciximab) Therapy. Circulation 1998;97;1214-1215.
  • Keung, YK, Lau SK: Medical Care of Prisoners: Controversial or not? Southern Medical Journal. 91(10):992, October 1998
  • Gadallah S, Lau SK, Chandraratha PA: Comparison of the hyperemic response to intracoronary and intravenous Adenosine by intracoronary Doppler flow recording
    – Abstracts from the 68th Scientific Sessions. Circulation suppl 1995,92(8): 1- 326.
  • Keung YK, Lau, SK, Gill P, Elkayam U, Chen SC, Dauer D: Cardiac arrhythmia after infusion of Cryopreserved stem cells. Bone Marrow Transplantation 1994, 14:363-367.
  • Keung YK, Lau, SK, Gill P: Extramedullary plasmacytoma of the heart presenting as cardiac emergency – review of literature. Am J. Clin Oneal 1994, 17(5):427- 429.
  • Lau SK, Faxon DP: Restenosis in Coronary Artery Intervention. In: Handbook of Cardiovascular Intervention (Bertrand, Serruys, Sigwart). Churchchill Livingston. London, UK.